Assessments of global drivers of vaccine hesitancy in 2014 - Looking beyond safety concerns

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Marti, Melanie ^a   De Cola, Monica ^a   MacDonald, Noni E ^b   Dumolard, Laure ^a   Duclos, Philippe ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; ARTICLE; AWARENESS; CONTROLLED STUDY; DRUG SAFETY; FEAR; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HUMAN; IMMUNIZATION; MEDICAL INFORMATION; PROGRAM EVALUATION; RELIGION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEX DIFFERENCE; SOCIOECONOMICS; VACCINATION REFUSAL; ATTITUDE TO HEALTH; FEMALE; MALE; QUESTIONNAIRE;

VACCINE;

ATTITUDE TO HEALTH; FEMALE; HUMANS; IMMUNIZATION; MALE; SURVEYS AND QUESTIONNAIRES; VACCINES;

EID: 85014300212     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0172310     Document Type: Article

References (17)

1. MacDonald NE, the SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy definition, scope and determinants. Vaccine. 2015; 33 (34): 4161-4164. doi: 10.1016/j.vaccine.2015.04.036 PMID: 25896383
2. Larson HJ, Jarrett C, Schulz WS, Chaudhuri M;, Zhou Y, Dube E, et al. Measuring vaccine hesitancy: The development of a survey tool. Vaccine. 2015; 33 (34): 4165-4175. doi: 10.1016/j.vaccine.2015.04.037 PMID: 25896384
3. World Health Organization Global Vaccine Action Plan (2014). Available: www.who.int/immunization/global-vaccine-action-plan/GVAP-doc-2011-2020/en/.
4. SAGE working group dealing with vaccine hesitancy [established March 2012]. Available: www.who.int/immunization/sage/sage-wg-vaccine-hesitancy-apr12.
5. SAGE Decade of Vaccines Working Group [established March 2013]. Available: www.who.int/immunization/sage/sage-wg-decade-vaccines.
6. WHO/UNICEF Joint Reporting Process. Available: www.who.int/immunization/monitoring-surveillance/routine/reporting/reporting.
7. Duclos P, Dumolard L, Abeysinghe N, Adjagba A, Janusz CB, Mihigo R, et al. Progress in the establishment and strengthening of national immunization technical advisory groups: Analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012. Vaccine. 2013; 31 (46): 5314-5320. doi: 10.1016/j.vaccine.2013.08.084 PMID: 24055304
8. World Health Organization Countries. Available: www.who.int/countries.
9. The 2014 World Bank Development Indicators Online. Available: http://www.data.worldbank.org/indicator.
10. United Nations, Department of Economic and Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision, DVD Edition.
11. Kieny MP, Evans DB, Schmets G, Kadandale S. Health-system resilience: reflections on the Ebola crisis in western Africa. Bull World Health Organ. 2014; 92(12): 850. doi: 10.2471/BLT.14.149278 PMID: 25552765
12. Muscat M. Who Gets Measles in Europe? The Journal of Infectious Diseases. 2001; 204:S353-S365.
13. Dube E, Gagnon D, Nickels E, Jeram S, Schuster S. Mapping vaccine hesitancy - Country-specific characteristics of a global phenomenon. Vaccine. 2014; 32 (49): 6649-6654. doi: 10.1016/j.vaccine.2014.09.039 PMID: 25280436
14. Eskola J, Duclos P, Schuster M, MacDonald NE, the SAGE Working Group on Vaccine Hesitancy. How to deal with vaccine hesitancy? Vaccine. 2015; 33 (34): 4215-4217. doi: 10.1016/j.vaccine.2015.04.043 PMID: 25896378
15. Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine. 2014; 32 (19): 2150-2159. doi: 10.1016/j.vaccine.2014.01.081 PMID: 24598724
16. Grabenstein J. What the World's religions teach, applied to vaccines and immune globulins. Vaccine. 2013; 31 (16): 2011-2023. doi: 10.1016/j.vaccine.2013.02.026 PMID: 23499565
17. Leask J, Willaby HW, Kaufman J. The big picture in addressing vaccine hesitancy. Human Vaccines & Immunotherapeutics. 2014; 10:9, 2600-2602.